| Similar Articles |
|---|
 |
The Motley Fool
January 23, 2004
Jean Graham |
Keeping Abreast of Implants Inamed's race with Mentor for first rights to the silicone breast implant market hits a snag.   |
The Motley Fool
August 4, 2004
Roger Nusbaum |
Inamed Waiting for Good News This multifaceted medical device company, which sells breast implants, awaits an FDA decision. The biggest risk is the stock getting caught in a general health sector downturn. |
BusinessWeek
April 25, 2005
Catherine Arnst |
Breast Implants: Science vs. Emotion Lobbying and politics are having a huge effect on the debate over whether to allow silicone breast implants back on the market. |
The Motley Fool
November 22, 2006
Brian Lawler |
Implant Approval Gives Allergan a Lift The return of silicone breast implants continues. Shares of Allergan, best known for its Botox wrinkle treatment, were up nearly 8% on the news. |
The Motley Fool
March 21, 2005
Rich Duprey |
Inamed Buoyant on Medicis Buyout Breast-implant maker Inamed will be acquired in a $2.8 billion deal with skin-care pharmaceutical Medicis. Inamed investors should now decide whether they want to be a part of Medicis or enjoy the profits realized from the offer. |
The Motley Fool
December 16, 2005
Stephen D. Simpson |
A Romantic Rectangle in Health Care First Medicis wants Inamed, then Allergan wants Inamed. Now Mentor wants Medicis. Strange days in health care, to be sure. Investors, take note. |
The Motley Fool
August 8, 2006
Stephen D. Simpson |
Waiting on Fine Figures From Mentor Flush with cash, medical aesthetics specialist Mentor needs to reinvest in growth. This is a fine company that rarely trades cheap -- investors, take note. |
The Motley Fool
May 19, 2006
Jim Mueller |
Foolish Forecast: Mentor's Uncertain Results Factors outside of the cosmetic surgery products maker's control are leading to short-term uncertainty. Investors, take note. |
The Motley Fool
January 15, 2009
Robert Steyer |
Medicis Tries to Save Face The wrinkle-removal drugmaker hopes it can smooth out a tough economy. |
The Motley Fool
February 9, 2006
Stephen D. Simpson |
Mentor Needs Some Prettying Up Until new products are approved or acquired, the aesthetics and urology company seems stuck in suspended animation. Just standing in place is not going to build much shareholder value. |
The Motley Fool
December 15, 2003
Alyce Lomax |
No Wrinkles for Medicis Medicis Pharmaceuticals announced that the FDA has approved its injectable wrinkle-filling gel, Restylane. Allergan's Botox has found a new competitor in the fountain-of-youth market. |
Chemistry World
August 1, 2006
Victoria Gill |
Breast Implant Study `Probably Flawed' The editors of a journal that published a study linking silicone breast implants with higher than normal levels of platinum in the circulation have urged caution when interpreting the findings. |
The Motley Fool
January 31, 2007
Brian Lawler |
No Earnings Face-Lift Needed For Allergan The ophthalmic and plastic surgery product developer has made many investors rich, and it's not stopping now. |
The Motley Fool
May 6, 2009
Robert Steyer |
Getting Ahead by Getting Rid of Wrinkles Medicis gets the FDA OK for an anti-wrinkle product as the market for Botox and other cosmetic skin drugs sags. |
Health
January 5, 2010
Susan Hall |
Thinking About Cosmetic Surgery? Here's How to Get a Better Nip or Tuck We reveal what it's like to have the three most popular procedures and whether those money-saving alternatives people talk about are worth it. |
The Motley Fool
January 2, 2004
Dave Marino-Nachison |
Medicis: Skin Is In The drug maker has a strong balance sheet and a commitment to product development. |
AskMen.com
Dustin Driver |
Male Plastic Surgery If you're thinking about surgical body modifications, keep reading. The following procedures can be performed in a matter of hours by a skilled plastic surgeon. |
